Histone lysine acetylation is central to epigenetic control of gene transcription. The bromodomain, found in chromatin-associated proteins and histone acetyltranferases, functions as the sole protein module known to bind acetyl-lysine motifs. Recent structural and functional analyses of bromodomains' recognition of lysine-acetylated peptides derived from major acetylation sites in histones and cellular proteins provide new insights into differences in ligand binding selectivity as well as unifying features of histone recognition by the bromodomains. These new findings highlight the functional importance of bromodomain/acetyl-lysine binding as a pivotal mechanism for regulating protein-protein interactions in histonedirected chromatin remodeling and gene transcription. These new studies also support the notion that functional diversity of a conserved bromodomain structural fold is achieved by evolutionary changes of structurally flexible amino-acid sequences in the ligand binding site such as the ZA and BC loops.
Introduction
Epigenetic regulation of gene activation and silencing in response to physiological and environmental stimuli has been shown to be dictated by chemical modifications of the DNA (for example, methylation of cytosine) and of the chromosomal DNA-packing histones (for example, acetylation, methylation, phosphorylation, ubiquitination and sumoylation) (reviewed in Fischle et al., 2003; Qiu, 2006; Kouzarides, 2007; Li et al., 2007) . A unifying model has emerged from chromatin biology to suggest an 'epigenetic code' that is embedded within chromatin to signify regions of distinct nuclear activities such as heterochromatin formation or transcriptional activation (Strahl and Allis, 2000; Jenuwein and Allis, 2001; Turner, 2002; Qiu, 2006) . The enigmatic code is hypothesized to be established by chromatin-modifying enzymes and interpreted by proteins that bind the chromatin in a modification-dependent manner that ultimately determines the outcome of expression or silencing of genes in response to extracellular stimuli. The discovery of evolutionarily conserved modular structural domains that are present in many chromatin-associated proteins and interact with chromatin in a sequence-dependent fashion provides the experimental evidence supporting this working hypothesis. These include the methyl-CpG-binding domain that recognizes methyl-cytosine in chromosomal DNA (Berger and Bird, 2005) ; the bromodomain that recognizes acetyllysine (Kac) in hitsones (Dhalluin et al., 1999; Jacobson et al., 2000; Zeng and Zhou, 2002) ; and the 'royal' protein family of chromo, tudor and MBT domains (Bannister et al., 2001; Lachner et al., 2001) , as well as the more recently described PHD fingers Pena et al., 2006; Shi et al., 2006; Wysocka et al., 2006) that recognize methyl-lysine in histones (Ruthenburg et al., 2007) . Of the histone modifications, lysine acetylation that is possibly among the first recognized modifications on histones (Allfrey et al., 1964) is highly dynamic and plays an important role in directing chromatin remodeling and gene transcription (Turner, 1998; Berger, 2002; Neely and Workman, 2002) ; the bromodomain is the only family of protein domains that is presently known to recognize acetyl-lysine (Zeng and Zhou, 2002) . In this review, we describe the current understanding of the unique structural features and ligand-binding specificity of the bromodomain.
Three-dimensional structure of the bromodomain Consistent with the reversible nature of lysine acetylation, the bromodomain and acetyl-lysine interaction is dynamic and likely transient in cells. This is supported by the three-dimensional structure of the bromodomain, as first revealed with that of the bromodomain from the human transcriptional coactivator PCAF (p300/CBPassociated factor) (Dhalluin et al., 1999) . A number of three-dimensional structures of the bromodomains, either in the free form or bound to an acetyl-lysinecontaining peptide derived from histones or other transcriptional proteins have been reported in the literature, which include those from human transcriptional protein TAFII250 (Jacobson et al., 2000) , human and Saccharomyces cerevisiae GCN5 (Hudson et al., 2000; Owen et al., 2000) , human PCAF (Mujtaba et al., 2002) , human coactivator CBP (CREB-binding protein) (Mujtaba et al., 2004) , human BET (bromodomains and extra terminal domain) family protein BRD2 (Nakamura et al., 2007) , human transcription factor BPTF (bromodomain and PHD domain transcription factor) , and human SWI/SNF chromatinremodeling complex protein Brg1 (Brahma-related gene 1) (Shen et al., 2007) . These structures determined either in solution or crystalline state confirm the early prediction from the first bromodomain structure (Dhalluin et al., 1999) , which is that most, if not all of bromodomains adopt a conserved structural fold of a left-handed bundle of four helices (a Z , a A , a B , a C ) with the inter-helical ZA and BC loops of variable length and sequence, and that the latter loops constitute a hydrophobic pocket serving to stabilize the structure as well as to interact with the acetyl-lysine (Figure 1a) . The structurally flexible ZA loop likely determines the dynamic nature of acetyl-lysine binding. Notably, the structural features of bromodomain/acetyl-lysine recognition are in sharp contrast to those of chromo domain/methyl-lysine binding, in which a methyl-lysinecontaining sequence forms an anti-parallel b-strand to the b-barrel structure of the chromo domain protein (Jacobs and Khorasanizadeh, 2002; Nielsen et al., 2002) . The modular structure of the bromodomain with its N and C termini being located together on one end of the protein supports the notion that bromodomains function as a conserved structural unit for protein-protein interactions and that tandem or multiple bromodomain modules can be placed sequentially in a chromosomal protein to serve similar or distinct functions.
Acetyl-lysine binding by the bromodomain
Despite the conserved structural fold, the overall sequence similarity of the large bromodomain family is not high with major sequence variations in the ZA and BC loops (Jeanmougin et al., 1997) . Nevertheless, the amino acid residues engaged in acetyl-lysine recognition are among the most highly conserved residues in the large bromodomain family that correspond to residues Tyr760, Tyr802 and Asn803 in PCAF (Figures 1a  and b) . As revealed in an atomic detail in the crystal structure of yeast GCN5 bromodomain solved in complex with a lysine-acetylated peptide derived from histone H4 at K16 (A-Kac-RHRK ILRNSIQGI, where Kac is an N e -acetyl lysine) (Owen et al., 2000) , in addition to binding to the conserved Tyr364 and Tyr406 (corresponding to Tyr760 and Tyr802 in PCAF), the acetyl-lysine forms a specific hydrogen bond between the oxygen of the acetyl carbonyl group and the side-chain amide nitrogen of the conserved asparagine, Asn407 (corresponding to Asn803 in PCAF). A network of water-mediated hydrogen bonds with protein backbone carbonyl groups at the base of the cleft also contributes to acetyl-lysine binding. The critical role of these amino acid residues in acetyl-lysine recognition as confirmed by site-directed mutagenesis (Dhalluin et al., 1999) argues that the majority of the bromodomain family functions as the acetyl-lysine-binding domain. Notably, the key asparagine residue À that is Asn803 or Asn407 in PCAF or GCN5, respectively, is not present in a small subgroup of bromodomains such as that of human TIF1b (transcription intermediate factor 1b), implicating that these bromodomains may not have the capability of recognizing acetyl-lysine and that the conserved bromodomain structural fold may be adopted to endow molecular functions other than acetyl-lysine interaction.
Sequence-specific acetyl-lysine recognition by the bromodomain Sequence-specific lysine acetylation recognition by a bromodomain is dependent on how the bromodomain recognizes target protein residues flanking the acetyl-lysine, as demonstrated by the three-dimensional Figure 1 Structure and acetyl-lysine recognition of the bromodomain. (a) The 3D structure of the PCAF bromodomain bound to a lysine-acetylated peptide derived from histone H3 lysine 36. (b) Unifying features of site-specific histone recognition by the bromodomains, as illustrated by the PCAF bromodomain/H3-K36ac peptide complex. Three main ligand contact sites for the recognition of the acetyl-lysine, residues at (Kac þ /À1) and/or (Kac þ /À2) and residues at (Kac þ /À3) and beyond are color-coded in red, blue and green, respectively. (c) The 3D structure of PCAF bromodomain bound a H3-K36ac peptide with protein residues colorcoded f according to the degree of sequence conservation in the bromodomain family: red, highly conserved; purple, conserved; and white, not conserved.
Structure and acetyl-lysine recognition of the bromodomain S Mujtaba et al structures of bromodomains bound to Kac peptides derived from biological binding partners reported in the literature. These are yeast GCN5 bromodomain/H4-K16ac (Owen et al., 2000) , human PCAF bromodomain/ HIV-1 Tat-K50ac (Mujtaba et al., 2002) and human CBP bromodomain/p53-K382ac (Mujtaba et al., 2004) . The more recently solved 3D structures of the PCAF and CBP bromodomains bound to lysine-acetylated histone H3 and H4 peptides provide important new insights into the structural and molecular bases of how bromodomains recognize sequence-specific acetylation sites in histones (M-M Zhou, unpublished results) -a question that had remained unanswered until recently. Note that the bromodomains of PCAF and CBP represent two distinct subgroups of the bromodomain family (Zeng and Zhou, 2002) . These new structures show that for PCAF or PCAF-like bromodomains, the preferred acetyl-lysine binding site in histones should have a hydrophobic residue at (Kac þ 2) and an aromatic or positively charged residue at (Kac þ 3), whereas for the CBP or CBP-like bromodomains, the consensus target sequence contains hydrophobic residues at (Kac þ 1) and (Kac þ 2), and a positively charged residue at (KacÀ1) as well as an aromatic residue at (KacÀ2). Salient features in bromodomain/histone recognition emerged from the structural and biochemical analyses can be defined as three major contact points in the conserved bromodomain structural fold as illustrated using the structure of the PCAF bromodomain bound to a H3-K36ac peptide (Figure 1b) . First, acetyl-lysine is recognized by most, if not all of the bromodomains in a hydrophobic pocket embedded between the ZA and BC loops (red region, Figure 1b) . As the bromodomain residues engaged in acetyl-lysine recognition are among the most highly conserved residues in the large bromodomain family, which correspond to Tyr760, Tyr802 and Asn803 in PCAF. The latter forms a hydrogen bond with the amide nitrogen of the acetyl-lysine. Second, ZA and/or BC loop residues resided at the entrance of the acetyl-lysine binding pocket interact with one or two amino-acid residues at (Kac þ /À1) or (Kac þ /À2) adjacent to the acetyl-lysine in the target protein (blue region, Figure 1b) . These interactions reinforce the binding of the acetyl-lysine of the target sequence. Third, additional ZA and BC loop residues that face the backside of the bromodomain (for example, opposite to the a Z' helix) form hydrophobic and electrostatic interactions with target sequence residues at (Kac þ /À3) or even further away from the Kac (green region, Figure 1b ). In such a mode of interaction, the BC loop serves a major anchoring point that is sandwiched between the (Kac þ 3) residue on the back of the bromodomain and the acetyl-lysine side chain that is bound inside the hydrophobic pocket of the protein.
Although bromodomains may use similar regions of the conserved structural fold to interact with target proteins, their sequence variations in the highly flexible ZA and BC loops (change, addition and deletion of amino acids) attribute to their distinct histone-binding selectivity (Figure 1c) . Therefore, as illustrated in the structures of the PCAF and CBP bromodomains, functional diversity of bromodomains may be achieved by evolutionary changes of the structural features at the ligand-binding sites outside the conserved scaffold. Because of the relatively low-protein sequence similarity in the ligand-binding sites, the unifying structural features of bromodomains in ligand recognition with the conserved fold as described above may be useful for identifying new family members and assigning their functions. Given the high degree of sequence variations and structural flexibility of the ZA and BC loops, we expect that additional modes of molecular recognition by different bromodomains likely exist and new structural analysis of such bromodomains in complex with their biological ligands that may go beyond histones will be required to enhance our current understanding of the structure-function relationships of the large bromodomain family in chromatin biology.
Small molecules modulating biological functions of the bromodomain
The acetyl-lysine sequence-binding site in a bromodomain contains preformed structural cavity between the ZA and BC loops, making it suitable for binding to small molecules that block the protein-protein interactions. Using the structure-guided methods, small molecule chemical ligands have been developed which are shown to be capable of selectively blocking the PCAF bromodomain binding to HIV-1 Tat at the acetylatedlysine 50 (Zeng et al., 2005) or the CBP bromodomain binding to human tumor suppressor p53 at the acetylated-lysine 382 (Sachchidanand et al., 2006) . The structural analysis revealed that both PCAF and CBP specific lead compounds, that is NP1 (N1-4-methyl-2-nitro-phenyl-propane-1,3-diamine) (Figures 2a and b) and MS7972 (9-acetyl-2,3,4,9-tetrahydro-carbazol-1-1) (Figures 2c and d) , respectively, are situated at the entrance of the acetyl-lysine binding pocket by interacting with amino-acid residues in the ZA loop of the corresponding protein (Figures 2a and b) , thereby blocking the bromodomain interaction with its biological target protein. As many of the amino-acid residues in the ZA loop that interact with the lead compound are unique in the PCAF or CBP bromodomain, these chemical ligands are selective.
Although bromodomain binding to a biological ligand can be highly selective through recognition by specific amino acid residues anchoring around an acetyllysine, such molecular interactions are typically not very tight with affinity (K d ) ranging from 10 to 100 mM (Hudson et al., 2000; Jacobson et al., 2000; Owen et al., 2000; Mujtaba et al., 2002 Mujtaba et al., , 2004 . As such, smallmolecule chemical ligands can be used as powerful research tools to elucidate the biological functions of bromodomain proteins in cells. For instance, the CBP bromodomain ligand, MS7972 that binds the CBP bromodomain with K d of 19.6 mM, has been proven effective in assessing p53 transcriptional activity in cellular response to DNA damage (Sachchidanand et al., 2006) . As shown in the literature, p53 expression in U2OS cells is low in a resting state, due to its negative regulation by MDM2 (Haupt et al., 1997; Kubbutat et al., 1997) . Upon DNA damage stimulation by doxorubicin treatment, p53 becomes serine-phosphorylated in the N-terminal activation domain. Additionally, p53 is acetylated on its C-terminal lysines, promoting CBP recruitment via bromodomain/p53-K382ac binding, leading to histone acetylation and transcriptional activation of target genes, such as the cyclin-dependent kinase inhibitor p21 in cell cycle arrest (Barlev et al., 2001; Mujtaba et al., 2004) . As expected, treatment of U2OS cells with the CBP bromodomain ligand MS7972 at 200 mM, before the doxorubicin stimulation, results in a dramatic decrease of the doxorubicin-induced increase in p53 (Sachchidanand et al., 2006) . This instability of the lysine-acetylated p53 in transcriptional activation upon dissociation from CBP binding is likely due to rapid deacetylation by histone deacetylases and subsequent ubiquitination and degradation by MDM2. This effect is confirmed by the decrease in p53-mediated p21 activation. Collectively, this study suggests that inhibition of CBP bromodomain association with p53-K382ac by a small-molecule ligand can cause a rapid inactivation of p53 transcriptional activity through promoting protein instability by changes of its post-translational modification states. This study further illustrates the power of using bromodomain-specific small-molecule ligands to investigate the biological functions of bromodomain protein in gene transcriptional regulation.
Perspective
The biological functions of bromodomain recognition of site-specific histones can play an important role in epigenetic regulation of gene transcription that is coupled to chromatin remodeling, as demonstrated by recent biochemical studies of nucleosome assembly, retention and RNA polymerase elongation (Hassan et al., 2001 (Hassan et al., , 2002 Lemon et al., 2001; Workman, 2006) . Such specific bromodomain functions can facilitate chromatin remodeling-mediated nucleosome displacement (Fujiki et al., 2005; Hassan et al., 2006) leading to recognition of a target promoter by a transcription initiation complex, and/or promote elongation of the transcription complex. For example, Rsc4, a component of yeast chromatin remodeling complex RSC, contains two bromodomains that bind H3-K14ac, resulting in promotion of gene activation (Kasten et al., 2004) . Yeast Bdf1 competes with HDAC Sir2 for binding to acetylated H4, and prevents Sir proteins from spreading into euchromatin to silence its promoters, thereby, establishing a boundary for heterochromatin (Ladurner et al., 2003) . The Bdf1 and histone H4 interaction compensates for an inaccessible TATA box by recruiting TFIID to its promoter to initiate transcription (Martinez-Campa et al., 2004) . The double bromodomain protein BRD4 plays a key role in pTEFb-mediated transcription by RNA polymerase II through its interactions with acetylated histones (Dey et al., 2000 (Dey et al., , 2003 Jang et al., 2005) , as well as in the papillomavirus E2 transcriptional activation (Schweiger et al., 2006) . Lysine acetylation of nucleosomes promotes recruitment of RSC via its bromodomain to the nucleosomes (Carey et al., 2006) . Bromodomain/acetyl-lysine interaction may also help explain the underlying mechanisms of the phenotypes linked to bromodomain deletion. For example, a bromodomain module is indispensable for the function of GCN5 in yeast (Georgakopoulos et al., 1995; Syntichaki et al., 2000) . Deletion of a bromodomain in HBRM in the human SWI/SNF complex causes Structure and acetyl-lysine recognition of the bromodomain S Mujtaba et al decreased stability and loss of nuclear localization (Muchardt et al., 1998; Muchardt and Yaniv, 1999) . Bromodomains of S. cerevisiae Bdf1 are required for sporulation and normal mitotic growth (Chua and Roeder, 1995) . Bromodomain deletion in members of RSC remodeling complex, causes a conditional lethal phenotype (Du et al., 1998) or a phenotypic inhibition on cell growth (Cairns et al., 1999) . Transgenic mice with lymphoid-restricted overexpression of the double bromodomain protein 2 develop splenic B-cell lymphoma and leukemia (Greenwald et al., 2004) . Finally, the bromodomain can functionally coordinate with adjacent conserved protein module(s) in a chromosomal protein, as illustrated by the tandem bromodomain and PHD finger motif in TIP5 of the NoRC remodeling complex (Zhou and Grummt, 2005) , and in BPTF (bromodomain and PhD finger transcription factor) . The latter PHD finger has been shown to function to bind selectively to the methylated lysine 4 in histone H3 , thereby providing an epigenetic mechanism of transcriptional control through molecular interactions of multiple histone modifications in a combinatorial manner. High-density post-translational amino-acid modifications occur in cellular or viral transcriptional proteins, which are similar to those in histones and modified even by the same set of histone modifying enzymes. Thus, bromodomain/acetyl-lysine recognition plays a direct role in mediating the consequential functions of lysine acetylation of these cellular or viral proteins. For instance, transcription activation of the integrated HIV-1 pro-virus is dependent on a molecular interaction between lysine-acetylated viral trans-activator Tat and the bromodomain of the cellular coactivator PCAF (Dorr et al., 2002; Mujtaba et al., 2002) . Human p53 transcriptional activity requires binding of its C-terminal acetylated K382 to the bromodomain of the coactivator CBP that is required for p53/coactivator recruitment after DNA damage, a step essential for p53-induced activation of its target genes such as p21 (Mujtaba et al., 2004; Sachchidanand et al., 2006) . Notably, lysine methylation of p53 (Chuikov et al., 2004; Huang et al., 2006 ) also occurs in a short stretch of its C-terminal sequence, where lysine acetylation sites are located. Therefore, we postulate that there exists a protein-protein interaction network interconnected through modifications on histones and transcriptional proteins that serves an overall epigenetic regulatory mechanism of gene transcriptional activation and silencing.
In summary, the recent progress in the structurefunction analyses of bromodomains yields new insights into site-specific histone lysine-acetylation directed epigenetic regulation of gene transcription. The emerging knowledge of the consensus recognition sequences for different but representative bromodomains will undoubtedly facilitate further elucidation of the molecular mechanisms underlying the role of the bromodomain proteins in chromatin biology. Given the high degree of sequence variations and structural flexibility of the ZA and BC loops that constitute the acetyl-lysine binding pocket, we expect that additional modes of molecular recognition likely exist for the large bromodomain family. The understanding of such new modes of molecular recognition will require more structural analysis of bromodomains in complex with their biological ligands of histones as well as other cellular proteins. Such studies are expected to help us understand how the conserved bromodomain fold is used as a structural template to exert a genome-wide lysine acetylation-directed mechanism together with lysine methylation and other histone modifications in epigenetic control of gene transcription and silencing.
Abbreviations CBP, CREB-binding protein; PCAF, p300/CBP-associated factor.
